Study #2013-0657
Most Closely HLA Matched Allogeneic CMV Specific Cytotoxic T-Lymphocytes (CTL) to Treat CMV Infection after Hemapoietic Stem Cell Transplantation (HSCT)
MD Anderson Study Status
Not Accepting
Treatment Agent
Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
Description
This phase II trial studies how well donor cytomegalovirus-specific cytotoxic T-lymphocytes work in treating patients with a cytomegalovirus infection that has come back or has not gotten better despite standard therapy. White blood cells from donors who have been exposed to cytomegalovirus may be effective in treating patients with a cytomegalovirus infection.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Cytomegaloviral Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Study phase:
Phase II
Physician name:
Betul Oran
Department:
Stem Cell Transplantation
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.